We are live on
!
Find out more
HL
HeadInvest LLC Portfolio holdings
AUM
$488M
1-Year Est. Return
14.33%
This Fund
S&P 500
This Quarter
Est. Return
+5.78%
1 Year Est. Return
+14.33%
3 Year Est. Return
+45.6%
5 Year Est. Return
+60.16%
10 Year Est. Return
+205.21%
AUM
$348M
AUM Growth
+$18.5M
(+5.6%)
Cap. Flow
-$650K
Cap. Flow
% of AUM
-0.19%
Top 10 Holdings %
Top 10 Hldgs %
30.93%
Holding
202
New
14
Increased
82
Reduced
72
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$442K |
| 2 |
iShares MSCI KLD 400 Social ETF
DSI
|
+$388K |
| 3 |
TJX Companies
TJX
|
+$253K |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$249K |
| 5 |
Invesco S&P 500 Equal Weight Technology ETF
RSPT
|
+$239K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$1.48M |
| 2 |
CELG
Celgene Corp
CELG
|
+$620K |
| 3 |
Merck
MRK
|
+$608K |
| 4 |
MBIA
MBI
|
+$545K |
| 5 |
Johnson & Johnson
JNJ
|
+$500K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.16% |
| 2 | Healthcare | 13.53% |
| 3 | Consumer Staples | 9.31% |
| 4 | Industrials | 8.13% |
| 5 | Energy | 3.78% |
Similar funds
UOIF
KCM
ACM
SCA
PE
GCM
RF
LCWP
HeadInvest LLC's Q4 2019 Portfolio in Review
As of Q4 2019, HeadInvest LLC held 202 positions worth $348M, up 5.6% from $330M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
HeadInvest LLC's Q4 2019 filing shows 14 new, 82 increased, 72 reduced and 3 closed positions. Its largest new stake was TJX Companies: 4,274 shares worth $261K. The largest sale was Idexx Laboratories, an estimated $1.48M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Staples.
- HeadInvest LLC's largest Q4 2019 buy was TJX Companies: 4,274 shares worth $261K.
- HeadInvest LLC added most to Bristol-Myers Squibb in Q4 2019, an estimated $442K increase.
- HeadInvest LLC's biggest Q4 2019 reduction was Idexx Laboratories, cutting an estimated $1.48M.
- HeadInvest LLC fully exited Celgene Corp in Q4 2019, selling an estimated $620K.
- HeadInvest LLC's ten largest holdings make up 31% of its $348M portfolio in Q4 2019.
- HeadInvest LLC opened 14 new positions and closed 3 in Q4 2019.
- HeadInvest LLC's portfolio value rose 5.6% quarter-over-quarter to $348M.
Based on HeadInvest LLC's 13F filing for Q4 2019, filed 14 Feb 2020.